TABLE 7.

The roles of miR-29b-3p in lung disease.

Author	Disease	Target/pathway	Role	Expression	Reference
Deng; He	Tissue fibrosis (including heart, liver, lung and kidney)	Binding to the 3ʹUTR	Inhibit collagen synthesist	—	He et al. (2013); Deng et al. (2017)
Liang; Xue	Cardiac fibrosis	TGF-β1/SMAD pathway	—	—	Liang et al. (2019); Xue et al. (2020)
Gong; Tao	Liver fibrosis	STAT3	Repress collagenous fibrosis	↓	Tao et al. (2018); Gong et al. (2020)
Lu	Liver fibrosis	TGF-β1	Activate COL1A1 expression	—	Lu et al. (2017)
Mullenbrock; Cushing; Pandit	PF	TGF-β1/SMAD pathway	Downregulate miR-29b and promote PF	↓	Cushing et al. (2011); Pandit et al. (2011); Cushing et al. (2015); Mullenbrock et al. (2018)
Wan	PF	—	Suppress fibroblast proliferation and decrease the level of hydroxyproline	—	Wan et al. (2020)